FUROSEMIDE\SPIRONOLACTONE: 245 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
245
Total FAERS Reports
8 (3.3%)
Deaths Reported
183
Hospitalizations
245
As Primary/Secondary Suspect
17
Life-Threatening
First Report: 19960318 · Latest Report: 20250705
What Are the Most Common FUROSEMIDE\SPIRONOLACTONE Side Effects?
#1 Most Reported
Hyperkalaemia
82 reports (33.5%)
#2 Most Reported
Syncope
62 reports (25.3%)
#3 Most Reported
Acute kidney injury
53 reports (21.6%)
All FUROSEMIDE\SPIRONOLACTONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperkalaemia | 82 | 33.5% | 0 | 75 |
| Syncope | 62 | 25.3% | 0 | 60 |
| Acute kidney injury | 53 | 21.6% | 0 | 50 |
| Dyspnoea | 52 | 21.2% | 0 | 48 |
| Hyponatraemia | 52 | 21.2% | 0 | 51 |
| General physical health deterioration | 51 | 20.8% | 0 | 51 |
| Dyspepsia | 50 | 20.4% | 0 | 46 |
| Eructation | 47 | 19.2% | 0 | 47 |
| Joint dislocation | 46 | 18.8% | 0 | 46 |
| Mitral valve incompetence | 46 | 18.8% | 0 | 46 |
| Vomiting | 46 | 18.8% | 0 | 46 |
| Anaemia | 45 | 18.4% | 0 | 45 |
| Arterial haemorrhage | 45 | 18.4% | 0 | 45 |
| Cardiovascular disorder | 45 | 18.4% | 0 | 45 |
| Diverticulum intestinal | 45 | 18.4% | 0 | 45 |
| Escherichia infection | 45 | 18.4% | 0 | 45 |
| Gastrointestinal haemorrhage | 45 | 18.4% | 0 | 45 |
| Groin pain | 45 | 18.4% | 0 | 45 |
| Haematuria | 45 | 18.4% | 0 | 45 |
| Decreased appetite | 44 | 18.0% | 0 | 44 |
Who Reports FUROSEMIDE\SPIRONOLACTONE Side Effects? Age & Gender Data
Gender: 80.2% female, 19.8% male. Average age: 76.5 years. Most reports from: IT. View detailed demographics →
Is FUROSEMIDE\SPIRONOLACTONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 0 |
| 2005 | 4 | 0 | 4 |
| 2008 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 1 |
| 2014 | 18 | 0 | 9 |
| 2015 | 16 | 0 | 14 |
| 2016 | 62 | 0 | 58 |
| 2017 | 8 | 0 | 7 |
| 2018 | 7 | 3 | 1 |
| 2019 | 22 | 0 | 19 |
| 2020 | 12 | 0 | 3 |
| 2021 | 8 | 0 | 8 |
| 2023 | 1 | 0 | 1 |
| 2024 | 4 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
What Is FUROSEMIDE\SPIRONOLACTONE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 120 |
| Hypertension | 23 |
| Cardiac failure | 11 |
| Hyperaldosteronism | 9 |
| Oedema | 8 |
| Hypertensive heart disease | 5 |
FUROSEMIDE\SPIRONOLACTONE vs Alternatives: Which Is Safer?
FUROSEMIDE\SPIRONOLACTONE vs FUSIDATE
FUROSEMIDE\SPIRONOLACTONE vs FUSIDIC ACID
FUROSEMIDE\SPIRONOLACTONE vs FUTIBATINIB
FUROSEMIDE\SPIRONOLACTONE vs GABAPENTIN
FUROSEMIDE\SPIRONOLACTONE vs GABAPENTIN ENACARBIL
FUROSEMIDE\SPIRONOLACTONE vs GADAVIST
FUROSEMIDE\SPIRONOLACTONE vs GADOBENATE DIMEGLUMINE
FUROSEMIDE\SPIRONOLACTONE vs GADOBUTROL
FUROSEMIDE\SPIRONOLACTONE vs GADODIAMIDE
FUROSEMIDE\SPIRONOLACTONE vs GADOLINIUM
Official FDA Label for FUROSEMIDE\SPIRONOLACTONE
Official prescribing information from the FDA-approved drug label.